Please assess the completion status of the following clinical trial:

Trial Title: Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females ≥ 18 yrs with atrial fibrillation (AF) and one or more of the following risk factors for stroke:~* Age ≥ 75, previous stroke~* transient ischemic attack (TIA) or Systemic Embolism (SE)~* Symptomatic congestive heart failure or left ventricular dysfunction with left ventricular ejection fraction (LVEF) ≤ 40%~* Diabetes mellitus or hypertension requiring pharmacological treatment

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): None
- 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).